Company intelligence / Profile preview

Veriton Pharma

Weybridge, Surrey, United Kingdomveritonpharma.com ↗

Ownership: Private
Employees: ~35
Development stage: Commercial

Overview

Veriton Pharma develops both licensed and unlicensed medicinal products, with a focus on epilepsy, neurology, and rare pediatric conditions. They have developed more than 60 "specials" for targeted therapeutic areas.

Therapeutic areas: Rare DiseasesNeurology
Modalities: Specialized medicinal products
Industry: Biotech

Drug pipeline

1 asset

Epistatus

Commercial

Indications: Epilepsy

Partnerships

Contract manufacturing partners (unnamed)

Beyond the preview

Go deeper on Veriton Pharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Veriton Pharma.

Explore the full profile